Read + Share
Vera R, Mata E, Gonzalez E, Juez I, et al. Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to
first line containing anti-EGFR? Int J Colorectal Dis 2020;35:739-746.
PMID: 32062727
|
 |
|
Vera R, Mata E, Gonzalez E, Juez I, et al. Is aflibercept an optimal treatment for wt RAS mCRC patients after progression to
first line containing anti-EGFR? Int J Colorectal Dis 2020;35:739-746.
PMID: 32062727
|
|
|
|